Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.

Last updated on 2020-05-29 History
Report ID 109626
Drug Identification Number 02173360
Brand name TEVA-SALBUTAMOL STERINEBS P.F.
Common or Proper name SALBUTAMOL 2MG/ML NEBS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SALBUTAMOL
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INHALATION
Packaging size 2.5ml
ATC code R03AC
ATC description ADRENERGICS, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-25
Estimated end date 2020-06-30
Actual end date 2020-05-27
Shortage status Resolved
Updated date 2020-05-29
Company comments Allocating to 100% of our market.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-05-29 French Compare
v7 2020-05-29 English Compare
v6 2020-05-21 French Compare
v5 2020-05-21 English Compare
v4 2020-05-08 French Compare
v3 2020-05-08 English Compare
v2 2020-03-26 French Compare
v1 2020-03-26 English Compare